Laminar Alterations in γ‐Aminobutyric AcidA, Muscarinic, and β Adrenoceptors and Neuron Degeneration in Cingulate Cortex in Alzheimer's Disease

Abstract: The laminar distribution of binding to a number of postsynaptic neurotransmitter receptors was assessed autoradiographically in postmortem samples of area 23a in posterior cingulate cortex from 13 Alzheimer and nine age‐matched control cases. Specific binding in all Alzheimer cases was compared to that in control cases, and the following alterations were observed: reduced muscimol binding in most layers; no changes in pirenzepine binding; and elevated cyanopindolol binding in layers Ic, IIIc, and IV. The Alzheimer cases were classified further on the basis of neuronal degeneration: class 1, no neuron loss; class 2, greatest losses in layer II or HI; class 3, greatest losses in layer IV; and class 4, greatest losses in layer V or VI. This classification uncovered further alterations in ligand binding patterns. First, muscimol binding was reduced in layers II and III only in class 2 cases and in layers V and VI only in class 4 cases. Second, pirenzepine binding was reduced in layers Ic, IIIa‐b, and VI of class 1 cases and layers Va and VI of class 4 cases. In spite of neuron degeneration in classes 2 and 3, there was no change in pirenzepine binding in these classes. Third, elevated cyanopindolol binding occurred in classes 3 and 4, whereas classes 1 and 2 had normal levels of binding. These results suggest that cases of Alzheimer's disease express heterogeneities in neocortical pathology which are reflected in the laminar patterns of binding to postsynaptic receptors. Reductions in muscimol binding to the γ‐aminobutyric acidA receptor had the closest relationship with neuron degeneration, whereas pirenzepine binding appeared to reflect a compensation in muscarinic receptors for changes in neuron densities.

[1]  D. Mash,et al.  Loss of high‐affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: Implications for the failure of cholinergic replacement therapies , 1991, Annals of neurology.

[2]  B. Vogt,et al.  Laminar distributions of muscarinic acetylcholine, serotonin, GABA and opioid receptors in human posterior cingulate cortex , 1990, Neuroscience.

[3]  B. Vogt,et al.  Cellular localization of serotonin 1A, 1B and uptake sites in cingulate cortex of the rat. , 1990, The Journal of pharmacology and experimental therapeutics.

[4]  M. Tabaton,et al.  Adrenergic Receptors in Aging and Alzheimer's Disease: Increased β2‐Receptors in Prefrontal Cortex and Hippocampus , 1989, Journal of neurochemistry.

[5]  R. Kalaria,et al.  Brain microvessels are innervated by locus ceruleus noradrenergic neurons , 1989, Neuroscience Letters.

[6]  L. Jarvik Aging of the brain: how can we prevent it? , 1988, The Gerontologist.

[7]  M. Farrant,et al.  "Run-down" of gamma-aminobutyric acidA receptor function during whole-cell recording: a possible role for phosphorylation. , 1988, Molecular pharmacology.

[8]  R. Wong,et al.  GABAA-receptor function in hippocampal cells is maintained by phosphorylation factors. , 1988, Science.

[9]  B. Vogt,et al.  Experimental localization of muscarinic receptor subtypes to cingulate cortical afferents and neurons , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[10]  E. Perry,et al.  Guanine nucleotide modulation of muscarinic cholinergic receptor binding in postmortem human brain — A preliminary study in Alzheimer's disease , 1987, Neuroscience Letters.

[11]  J. Penney,et al.  Cortical GABAB and GABAA receptors in Alzheimer's disease , 1987, Neurology.

[12]  E. Noble,et al.  Postmortem Changes in Rat Brain: Studies on Membrane‐Bound Enzymes and Receptors , 1987, Journal of neurochemistry.

[13]  D. Neary,et al.  Presynaptic Serotonergic Dysfunction in Patients with Alzheimer's Disease , 1987, Journal of neurochemistry.

[14]  D. Middlemiss,et al.  Binding of the Novel Serotonin Agonist 8‐Hydroxy‐2‐(Di‐n‐Propylamino) Tetralin in Normal and Alzheimer Brain , 1986, Journal of neurochemistry.

[15]  J. Rinne,et al.  Brain muscarinic receptors in senile dementia , 1985, Brain Research.

[16]  D. Mash,et al.  Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. , 1985, Science.

[17]  A. Cross,et al.  Serotonin Receptor Changes in Dementia of the Alzheimer Type , 1984, Journal of neurochemistry.

[18]  L. Iversen,et al.  Reduced binding of [3H]ketanserin to cortical 5-HT2 receptors in senile dementia of the Alzheimer type , 1984, Neuroscience Letters.

[19]  H. Henke,et al.  Cholinergic receptor binding and autoradiography in brains of non-neurological and senile dementia of Alzheimer-type patients , 1983, Brain Research.

[20]  D. Neary,et al.  Biochemical Assessment of Serotonergic and Cholinergic Dysfunction and Cerebral Atrophy in Alzheimer's Disease , 1983, Journal of neurochemistry.

[21]  J. Couch,et al.  Fundamentals of Statistics for the Behavioral Sciences , 1982 .

[22]  W. Bondareff,et al.  Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia , 1982, Neurology.

[23]  A. Brun,et al.  Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading , 1981, Histopathology.

[24]  G. Blessed,et al.  Cell loss in the locus coeruleus in senile dementia of Alzheimer type , 1981, Journal of the Neurological Sciences.

[25]  Michael J. Kuhar,et al.  A new method for receptor autoradiography: [3H]Opioid receptors in rat brain , 1979, Brain Research.

[26]  E. Bird,et al.  Pre- and postsynaptic neurochemical alterations in Alzheimer's disease , 1978, Brain Research.

[27]  E K Perry,et al.  Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. , 1978, British medical journal.

[28]  A. Björklund,et al.  Growth of vascular sympathetic axons into the hippocampus after lesions of the septo-hippocampal pathway: a pitfall in brain lesion studies , 1978, Neuroscience Letters.

[29]  D. Bowen,et al.  NEOCORTICAL CHOLINERGIC NEURONS IN ELDERLY PEOPLE , 1977, The Lancet.

[30]  J. Kurucz,et al.  RECENT OBSERVATIONS ON SENILE CEREBRAL CHANGES AND THEIR PATHOGENESIS , 1964, Journal of the American Geriatrics Society.

[31]  D. Bowen,et al.  Biochemical studies of nerve cells and energy metabolism in Alzheimer's disease. , 1986, British medical bulletin.